Professional Documents
Culture Documents
The cover illustration displays a-cyclodextrin with its MOLCAD program-generated contact
surface, onto which the molecular lipophilicity patterns (MLPs) are projected in a color code
ranging from blue (hydrophilic regions) to yellow (hydrophobic areas). The a-CO-donuts (top
entries) are viewed through the larger opening of the conically shaped molecule (left), thereby
exposing the intensely hydrophilic (blue) secondary hydroxyl face, or alternately, through the
smaller cone opening (right) revealing the surface areas above the six 6-CH20H groups to be
distinctly hydrophobic (yellow). The side view MLPs (lower entries), in closed fonn and bisected
with a ball- and stick-model insert, are oriented with the 2-0H/3-0H side (larger opening of the
torus) pointing upward; they clearly expose the distribution of hydrophillic (blue) and hydrophobic
(yellow) surface regions outside and inside the cavity. For further comments see F. W. Lichtenthaler and S. Immel, J. lnei. Phenom. Mol. Recogn. 25, 3-16 (1996), and pp. 3-16 of this volume.
Proceedings of the
Eighth International Symposium
on Cyclodextrins
Budapest, Hungary, March 31-Apri12, 1996
Edited by
Partly reprinted from Journal of Inclusion Phenomena, Vol. 25, Nos. 1-3, 1996
A C.I.P. Catalogue record for this book is available from the Library of Congress
ISBN 0-7923-4029-9
CONTENTS
1.1.
'"
'"
de Brauer, C., Claudy, P., Diot, M., Germain, P., LetotTe, J.M., Serpelloni, M.
Calorimetric Investigations of ~-Cyclodextrin Hydration Thermodynamic
Consequences of Water Exchange in Inclusion Reactions ...................................... 21
'"
Production of CDs
vi
1.3.
Ruebner, A., Moser, J.G., Kirsch, D., Spengler, B., Andrees, S., Roehrs, S.
Synthesis of J3-Cyclodextrin Dimers as Carrier Systems for Photodynamic
Therapy of Cancer ................................................................................................ 77
Nogami, Y., Fujita, K., Ohta, K., Nasu, K., Shimada, H., Shinohara, c.,
Koga, T.
A New Synthetic Strategy ofCyclooligosaccharides. Cyclodextrin-Derived
Cycloaltrins Made up from a.(l ~4)-Linked Altropyranoses .................................... 99
Fujita, K., Mizuochi, M., Koga, K., Ohta, K.
Selective One-Point Cleavage of Capped J3-Cyclodextrin by Taka-Amylase A
Two-Step Synthesis ofGlycophane from J3-Cyclodextrin ..................................... 103
Hattori, K., Imata, H., Kubota, K., Matsuda, K., Aoyagi, M., Yamamoto, K.,
Jindoh, Ch., Yamanoi, T., Inazu, T.
The Synthesis of Oligosaccharide-Branched Cyclodextrins and their Interaction
with Concanavalin A ........................................................................................... 121
vii
.137
Biological Properties
Antlsperger, G., Schmid, G.
Toxicological Comparison of Cyclodextrins ........................................................ 149
Shizuka, F., Hara, K., Hashimoto, H.
Dietary Fiber-Like Effects of Orally Administered Cyclodextrins in the Rat ."
. 157
. .. 175
.... 189
viii
Giordano, F., Rillosi, M., Bettinetti, G.P., Gazzaniga, A., Majewski, W.,
Perrot, M.
Interaction of Supercritical Fluids with Drug/Cyclodextrin Inclusion Compounds
and Physical Mixtures ......................................................................................... 193
Mondik, P., Sopkova, A., Viernstein, H., Legendre, B.
Cyclodextrins in the Role of Host and Simultaneously Guest Component ............ 197
2.2.
Structural Studies
Kohler, G., Grabner, G., Klein, e. Th., Marconi, G., Mayer, B., Monti, S.,
Rechthaler, K., Rotkiewicz, K., Viemstein, H., Wolschann, P.
Structure and Spectroscopic Properties of Cyclodextrin Inclusion Complexes ..... 215
ix
Zia, V., Bomancini, E.R., Luna, E.A., Rajewski, R.A., Stella, v.J.
Effect of Alkyl Chain Length and Degree of Substitution on Complexation of
Sulfoalkyl ~-Cyclodextrins with Testosterone and Progesterone .......................... 259
Enzyme-modeling
Ikeda, H., Nishikawa, S., Takaoka, J., Akiike, T., Yamamoto, Y., Ueno, A.,
Toda, F.
Cyclodextrin Homo- and Hetero-Dimers as Enzyme Models ............................... 277
Drug/CD-Complexes
~-Cyclodextrin
.......... 287
~-Cyclodextrin
Moyano, J.R., Gines, J.M., Arias, M.J., Perez-Martinez, J.I., Bettinetti, G.,
Giordano, F.
Study of Complexation of Gliclazide with ~-Cyclodextrin in Solution by NMR
Techniques .......................................................................................................... 309
xi
3.2.
Specific Formulations
Nakanishi, K., Masukawa, T., Nadai, T., Yoshii, K., Okada, S., Miyajima, K.
Prolonged Release of Drug from Triacetyl-f3CD Complex for Oral and Rectal
Administration .................................................................................................... 419
xii
Regdon, G. jr., Bacskay, I., Gergely, A.., Hodi, K., Regdon, G. sen., Kata, M.
Fenyvesi, E., Ujhazi, A., Szejtli, J., Piitter, S., Gan, T.G.
Controlled Release of Drugs from CD Polymers Substituted with Ionic Groups ... 443
Stella, V.J.
SBE7-I3-CD, a New, Novel and Safe Polyanionic I3-Cyclodextrin Derivative:
Characterization and Biomedical Applications ..................................................... 471
Everest-Todd, M.
Topical Application of Cyclodextrin Ethers in the Control of Pain ....................... 495
xiii
Biotechnology
Bar, R.
Application ofCyclodextrins in Biotechnology .................................................... 521
Donova, M.V., Dovbnya, D.V. Koschcheyenko, K.A.
Modified CDs-Mediated Enhancement of Microbial Sterol Sidechain
Degradation ........................................................................................................ 527
Kolossvary, G.J., Kolossvary, I., Banky-Elod, E.
In Vitro Study and Computational Simulation of Cyclodextrin Inclusion
Complexes in Enzymatic Lipid Hydrolysis ........................................................... 531
Ishaque, M., Sticht-Groh, V.
Degradation ofFattyacid-Cyclodextrin Complexes by Mycobacteria .................... 535
4.2.
Textile Industry
Trinh, T.
Cyclodextrins in Fabric Care Consumer Products ................................................ 541
Buschmann, H.-J.
CD Dye Complexes and their Use in Dyeing Processes ........................................ 547
Reuscher, H. Hirsenkorn, R.
Beta W7 MCT - New Ways in Surface Modification ........................................... 553
xiv
4.3.
4.4.
*
*
xv
*
*
In 1980 the cyclodextrins had been known for a long time, and during the
preceding 30 months 239 CD-related abstracts had been publi~Jted by the
Chemical Abstracts, i.e. the number of CD-related publications grew to
8/month. Several laboratories, companies, prepared CDs, but almost
exclusively for research purposes. A group of scientists, scattered worldwide in various laboratories, however, suspected that the CDs were more,
much more than only challenging curiosities, some of these people dreamed
about or even prognosticated the production of thousands of tons of CDs, to
be used in hundreds or thousands of products and technologies. At any rate,
in 1980 the time seemed to be adequate for an international CDSymposium.
I have sent letters to about 100 colleagues, working on cyclodextrins in
the preceding years asking for their opinion: is it timely to organize a small
CD-Symposium? The answers were unanimously YES. So we began to
organize a CD-Symposium. I expected 25-30 participants outside Hungary,
and in best case - including the presentations of Hungarian colleagues about 35-40 lectures. The fIrst surprise was that on 30th of September 1982,
the fIrst day of the Symposium from 17 countries more than 180
participants arrived and the submitted manuscripts fIlled a 544 page volume
(Proceedings of the 1st International Cyclodextrin Symposium, Akademiai
Kiad6, Budapest and Reidel, Pub!. Co., Dordrecht, 1982).
The second surprise on the last day of this Symposium was a question
from a group of Japanese colleagues: "Do you intend to organize the second
International Cyclodextrin Symposium, as well?" That was the very
moment when the Budapest International Cyclodextrin Symposium was
named by the serial number 1. The second CD Symposium was organized
by Professor Nagai in 1984 in Tokyo, and since that time every second year
the CD-Symposia have regularly been organized: Lancaster 1986
(Dr.Davies), Munich 1988 (Dr.Huber), Paris 1990 (Prof.Duchene), Chicago
1992 (Dr. Hedges), Tokyo 1994 (Prof.Nagai) and again Budapest in 1996.
By now, the production of CDs worldwide has reached the several
thousand ton per year level and is dynamically growing. Not only the a-, /3and yCDs are produced industrially, but also some derivatives, like randomxvii
xviii
Hammond,
IndianalUSA
Parma, Italy
Hettlingen, Switzerland
Gaineswille,
FloridalUSA
Budapest, Hungary
Cyclolab Ltd.
CyDex,L.C
Ensuiko Sugar Co.
Overland Park,
Kansas/USA
Yokohama, Japan
Janssen Biotech N. V.
Beerse, Belgium
Nagai Foundation
Dordrecht,
The Netherlands
Le Bar-sur-Loup,
France
Tokyo, Japan
Budapest, Hungary
Wacker-Chemie GmbH
Munich, Germany